Learning Objectives
After completing this activity, pharmacists should be able to:
- identify the use of insulin in the treatment of patients with type 1 and type 2 diabetes;
- describe the desired properties of basal and bolus insulins;
- distinguish between the properties of newer insulins and indicate the advice that should be given to patients using these therapies.
The 2016 Competency Standards addressed by this activity include: 1.4, 2.1, 3.1, 3.2, 3.3, 3.5, 3.6
Accreditation number: CX20062 Accreditation expires: 01/11/2022
This activity has been accredited for 0.5 hour of Group One CPD (or 0.5 CPD credit) suitable for inclusion in an individual pharmacist’s CPD plan, which may be converted to 0.5 hour of Group Two CPD (or 1.0 CPD credit) upon successful completion of the associated assessment activity.